-
NMPA Issues Requirements for Registration Classification and Application Dossiers of Chemical Drugs
2020-06-30
NMPA has organized to formulate the Requirements for Registration Classification and Application Dossiers of Chemical Drugs, which has been issued on June 29, 2020.
-
NMPA Issues Charging Standards for Drug Registration and Rules for Implementing Drug Registration Charges
2020-06-30
NMPA has formulated the Charging Standards for Drug Registration and Rules for Implementing Drug Registration Charges, which shall take effect as from July 1, 2020.
-
NMPA Issues the Writing Specification for Periodic Risk Evaluation Reports of Medical Devices
2020-06-24
NMPA has organized to formulate the Writing Specification for Periodic Risk Evaluation Reports of Medical Devices, which was issued on June 30, 2020.
-
NMPA Issues the Announcement on the Requirements for the Management of Drug Records and Data (Interim)
2020-06-24
NMPA has organized to formulate the Requirements for the Management of Drug Records and Data (Interim), which was issued on June 24, 2020 and shall come into force as of December 1, 2020.
-
NMPA Issues the Announcement on Upgrading Related Systems for Drug Registration
2020-06-17
To support the implementation of the newly revised Provisions for Drug Registration, NMPA is currently stepping up the upgrade of related systems for drug registration.
-
NMPA Issues Announcement on Revising Package Insert of Vitamin B2 Injection
2020-06-11
On June 11, 2020, NMPA issued an Announcement with decisions made to revise the [adverse reactions], [contraindications], etc. in the package insert of Vitamin B2 Injection.